TGFB1 and chronic kidney disease: In AVF, increased TGF-β signaling has been demonstrated in both humans and mice with CKD [52], and is associated with endothelial-to-mesenchymal transition, enhanced smooth muscle cell proliferation, increased AVF wall thickness, and reduced AVF patency [39,52].